Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Hwy, MS-S107-2, Atlanta, GA, 30341, USA.
United States Public Health Service, Commissioned Corps, Rockville, MD, 20857, USA.
J Perinatol. 2020 Mar;40(3):422-432. doi: 10.1038/s41372-019-0542-3. Epub 2019 Oct 30.
To describe obstetrician-gynecologists' practices and attitudes related to substance use screening in pregnant patients.
A 2017 cross-sectional survey assessed US obstetrician-gynecologists' (n = 462; response rate = 34%) practices (substance use screening frequency and methods) and attitudes (practice priority of screening, confidence in treating, and responsibility statements). Chi-squared tests and adjusted modified Poisson regression were used to estimate associations between practices and attitudes.
Of 353 respondents with screening information, 79% frequently screen for substance use and 11% used a validated instrument. Confidence was the highest for treating pregnant patients using tobacco (81%). Respondents whose practices make it a high priority to screen for all substances were 1.2 times as likely to frequently screen as their counterparts (95% CI: 1.1-1.3).
Four out of five obstetricians-gynecologists reported a high frequency of substance use screening in pregnant patients. Findings highlight the importance of increasing priority of substance use screening by obstetrician-gynecologists.
描述妇产科医生在孕妇药物使用筛查方面的实践和态度。
2017 年的一项横断面调查评估了美国妇产科医生(n=462;应答率=34%)的实践(药物使用筛查的频率和方法)和态度(筛查的优先实践、治疗信心和责任声明)。卡方检验和调整后的修正泊松回归用于估计实践和态度之间的关联。
在 353 名有筛查信息的受访者中,79%经常筛查药物使用情况,11%使用了经过验证的工具。对使用烟草治疗孕妇的信心最高(81%)。将所有物质的筛查作为高优先级的受访者,其经常筛查的可能性是其对应者的 1.2 倍(95%置信区间:1.1-1.3)。
五分之四的妇产科医生报告了对孕妇药物使用的高频率筛查。这些发现强调了增加妇产科医生对药物使用筛查的重视程度的重要性。